EMD-27252
gRAMP non-match PFS target RNA
EMD-27252
Single-particle3.6 Å

Map released: 31/08/2022
Last modified: 12/06/2024
Sample Organism:
Candidatus Scalindua brodae
Sample: Gramp-Non matching PFS target
Fitted models: 8d8n (Avg. Q-score: 0.435)
Deposition Authors: Hu C
,
Nam KH
,
Schuler G
,
Ke A
Sample: Gramp-Non matching PFS target
Fitted models: 8d8n (Avg. Q-score: 0.435)
Deposition Authors: Hu C




Craspase is a CRISPR RNA-guided, RNA-activated protease.
Hu C
,
van Beljouw SPB
,
Nam KH
,
Schuler G
,
Ding F
,
Cui Y
,
Rodriguez-Molina A
,
Haagsma AC
,
Valk M
,
Pabst M
,
Brouns SJJ
,
Ke A
(2022) Science , 377 , 1278 - 1285












(2022) Science , 377 , 1278 - 1285
Abstract:
The CRISPR-Cas type III-E RNA-targeting effector complex gRAMP/Cas7-11 is associated with a caspase-like protein (TPR-CHAT/Csx29) to form Craspase (CRISPR-guided caspase). Here, we use cryo-electron microscopy snapshots of Craspase to explain its target RNA cleavage and protease activation mechanisms. Target-guide pairing extending into the 5' region of the guide RNA displaces a gating loop in gRAMP, which triggers an extensive conformational relay that allosterically aligns the protease catalytic dyad and opens an amino acid side-chain-binding pocket. We further define Csx30 as the endogenous protein substrate that is site-specifically proteolyzed by RNA-activated Craspase. This protease activity is switched off by target RNA cleavage by gRAMP and is not activated by RNA targets containing a matching protospacer flanking sequence. We thus conclude that Craspase is a target RNA-activated protease with self-regulatory capacity.
The CRISPR-Cas type III-E RNA-targeting effector complex gRAMP/Cas7-11 is associated with a caspase-like protein (TPR-CHAT/Csx29) to form Craspase (CRISPR-guided caspase). Here, we use cryo-electron microscopy snapshots of Craspase to explain its target RNA cleavage and protease activation mechanisms. Target-guide pairing extending into the 5' region of the guide RNA displaces a gating loop in gRAMP, which triggers an extensive conformational relay that allosterically aligns the protease catalytic dyad and opens an amino acid side-chain-binding pocket. We further define Csx30 as the endogenous protein substrate that is site-specifically proteolyzed by RNA-activated Craspase. This protease activity is switched off by target RNA cleavage by gRAMP and is not activated by RNA targets containing a matching protospacer flanking sequence. We thus conclude that Craspase is a target RNA-activated protease with self-regulatory capacity.